120
Participants
Start Date
January 31, 2026
Primary Completion Date
January 31, 2028
Study Completion Date
July 31, 2028
Usual care for diabetic kidney disease management without primary care provider.
Participants in the control group will receive usual care for diabetic kidney disease which includes virtual care, walk-in clinics, or mobile health clinics for people without a primary care provider.
Pharmacist-led validated diabetic kidney disease decision support algorithm.
Pharmacist working in community pharmacy primary care clinic in Nova Scotia will utilize previously validated diabetic kidney disease decision support algorithms for renin-angiotensin system inhibitors (RASi), sodium-glucose co-transporter 2 inhibitors (SGLT2i), or nonsteroidal mineralocorticoid receptor antagonists (nsMRA).
Nova Scotia Health Authority
OTHER